The 17 references in paper S. Sharapova O., A. Pozdnyakova S., S. Aleshkevich N., A. Migas A., M. Belevtsev V., C. Шарапова О., А. Позднякова С., С. Алешкевич Н., А. Мигас А., М. Белевцев В. (2014) “ПОВЫШЕННАЯ ЧУВСТВИТЕЛЬНОСТЬ К MYCOBACTERIUM TUBERCULOSIS У ПАЦИЕНТОВ С Х-СЦЕПЛЕННОЙ ХРОНИЧЕСКОЙ ГРАНУЛЕМАТОЗНОЙ БОЛЕЗНЬЮ // INCREASED SUSCEPTIBILITY TO MYCOBACTERIUM TUBERCULOSIS IN PATIENTS WITH X-LINKED CHRONIC GRANULOMATOUS DISEASE” / spz:neicon:pulmonology:y:2011:i:1:p:50-54

1
Notarangelo L.D. Primary immunodeficiencies. J. Allergy Clin. Immunol. 2010; 125 (2): 182–194.
(check this in PDF content)
2
Notarangelo L.D., Fischer A., Geha R.S. et al.Primary immunodeficiencies: 2009 update. J. Allergy Clin. Immunol. 2009; 124: 1161–1178.
(check this in PDF content)
3
Reichenbach J., Rosenzweig S., Doffinger R. et al. Mycobacterial diseases in primary Immunodeficiencies. Curr. Opin. Allergy Clin. Immunol. 2001; 1: 503–511.
(check this in PDF content)
4
Cooper A.M.Cell-mediated immune responses in tuberculosis. Ann. Rev. Immunol. 2009; 27: 393–422.
(check this in PDF content)
5
North R.J., Jung Yu.%J. Immunity to tuberculosis. Ann. Rev. Immunol. 2004; 22: 599–623.
(check this in PDF content)
6
Al%Muhsen S., Casanova J.%L. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J. Allergy Clin. Immunol. 2008; 122 (6): 1043–1051.
(check this in PDF content)
7
Ochs H.D., Smith C.I.E., Puck J.M. Primary immunodeficiency diseases, a molecular and genetic approach, second edition. New York: Oxford University Press; 2007.
(check this in PDF content)
8
Berg J.M., van Koppen E., Ahlin A. et al.Chronic granulomatous disease: The European experience. PLoS One 2009; 4 (4): 1–10.
(check this in PDF content)
9
Rodrigues L.C., Divan V.K., Wheeler J.G.Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: A meta-analysis. Int. J. Epidemiol. 1993; 22 (6): 1154–1158.
(check this in PDF content)
10
Леви Д.Т., Аксенова В.А., Закирова Н.Р. и др.Вакцинация БЦЖ: характеристика препаратов и причины поствакцинальных осложнений. Пробл. туб. 1999; 4: 4–7.
(check this in PDF content)
11
Sadeghi%Shanbestari M., Ansarin K., Maljaei S.H. et al. Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran. Ital. J. Pediatr. 2009; 35 (42): 1–5.
(check this in PDF content)
12
Elloumi H.Z., Holland S.M. Diagnostic assays for chronic granulomatous disease and other neutrophil disorders. Meth. Mol. Biol.: Neutrophil Meth. Protocols. 2007; 412: 505–523.
(check this in PDF content)
13
Hesseling A.C., Rabie H., Marais B.J. et al.Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin. Infect. Dis. 2006; 42 (4): 548–558.
(check this in PDF content)
14
Bustamante J., Aksu G., Vogt G. et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J. Allergy Clin. Immunol. 2007; 120 (1): 32–38.
(check this in PDF content)
15
Jou R., Huang W.L., Su W.J. Tokyo-172 BCG vaccination complications, Taiwan. Emerg. Infect. Dis. 2009; 15 (9): 1525–1526.
(check this in PDF content)
16
McShane H. Vaccine strategies against tuberculosis. Swiss. Med. Wkly 2009; 139 (11–12): 156–160.
(check this in PDF content)
17
Swaminathan S., Rekha B.Pediatric tuberculosis: global overview and challenges. Clin. Infect. Dis. 2010; 15 (50, suppl. 3): 184–194. Информация об авторах Шарапова Светлана Олеговна – аспирант научного отдела лаборатории
(check this in PDF content)